Andreas Halvorsen’s Viking Global Portfolio: 5 New Stock Picks

Page 5 of 5

1. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA

Viking Global’s Stake Value: $3,511,109,000

Percentage of Viking Global’s 13F Portfolio: 9.74%

Number of Hedge Fund Holders: 32

Andreas Halvorsen, via Viking Global, purchased almost 303 million shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) in the third quarter, making the new stock addition the largest holding in the hedge fund’s portfolio. Halvorsen’s $3.51 billion stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) accounts for 9.74% of his total Q3 investments. 

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a Massachusetts-based biotechnology company engaged in genetics engineering, producing bacteria with industrial applications.

On November 29, Jefferies analyst Laurence Alexander initiated coverage of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) with a Buy rating and a $16 price target, stating that he expects the company to monetize the value of its programs through a mix of royalties, license payments, and equity share, resulting in forecasted free cash flow turning positive in 2025. 

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) posted Q3 results on November 15, with EPS in the period equaling -$0.08, missing estimates by -$0.05. Revenue for the quarter totaled $77.61 million, outperforming estimates by $31.61 million. 

Of the 867 hedge funds monitored by Insider Monkey in Q3 2021, 32 funds reported owning stakes in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), worth $5.69 billion. 

You can also take a look at Japanese Billionaire Masayoshi Son’s Investments: Top 10 Stock Picks and Bill Gates Portfolio: Most Recent Investments.

Page 5 of 5